Haute Health Canada presents insights on Emotionally Unstable Personality Disorder (EUPD), also known as Borderline Personality Disorder (BPD). This disorder affects emotional stability and social interactions, leading to impulsive or self-harming behavior. Treatment costs can be high, with success rates ranging from 35% to 50%. Researchers at Haute Health Canada are exploring alternative treatment avenues to improve existing therapies.
One potential treatment option for EUPD is cannabis, widely recognized as weed. Cannabis is an affordable option, and its compounds may provide benefits for individuals coping with EUPD. Those who cannot afford multiple treatment modalities might search for cannabis online to find budget-friendly alternatives.
Table of Contents
Key Takeaways:
- Patients with EUPD using THC or high-CBD products report positive results in managing their symptoms.
- High doses of CBD (800 mg/day) and THC flower treatments may enhance circulating levels of anandamide.
- Dysfunction in the endocannabinoid system, which regulates emotions and stress, is linked to Emotionally Unstable Personality Disorder.
Understanding EUPD and BPD
EUPD is a mental health condition that impacts self-image and interpersonal relationships, resulting in difficulties in daily life. Key characteristics include intense, unstable relationships, impulsivity, and a distorted self-image.
While the exact origins remain unclear, factors such as genetics, trauma, and neurotransmitter imbalances may play a role. Dysfunction in the endocannabinoid system, which modulates emotions and stress, may exacerbate EUPD symptoms.
EUPD Treatment Options
Although no medications are definitively proven effective for EUPD, healthcare providers often prescribe antipsychotics and antidepressants.
Antipsychotics and sedatives may assist in short-term crisis management or in addressing coexisting conditions. A significant percentage of individuals with EUPD—up to 90% in some studies—utilize at least one cannabis, which includes antipsychotics, antidepressants, mood stabilizers, and sedatives.
Polypharmacy is common in these patients, with many medications associated with side effects and frequently prescribed off-label for EUPD. While some medications may alleviate specific symptoms, they do not change the overall prognosis of the disorder.
Cannabis-Based Medicine for EUPD (CBM)
Cannabis-based medicines originate from the cannabis plant and contain cannabinoids, the active components such as THC and CBD. These products address various medical conditions, including pain, inflammation, anxiety, and seizures.
Research is actively exploring the effects on mental health. Studies indicate that marijuana can relieve depression and enhance sleep quality, supporting further investigation into marijuana’s impact on various mental health disorders.
CBM for Managing Unstable Personality Disorder
A narrative review and case study in 2022 highlighted the effectiveness of cannabinoids in reducing EUPD symptoms among seven patients. Researchers examined the cellular and molecular mechanisms and evaluated current evidence for cannabis-based medicinal products (CBMP) as a possible treatment for EUPD.
Materials and Methods
Participants included individuals diagnosed with EUPD who had previously attempted at least one medication and one type of psychotherapy, with follow-ups at a Zerenia clinic and patient-reported outcome measures (PROMS) records.
The CBM utilized involved dried flower for inhalation (20-60g per month) and oral extracts with THC (9-10mg/day) and CBD (40mg/day). The formulations included various chemotypes: High THC, low CBD; Balanced THC and CBD; and High CBD, low THC.
Measurements were assessed using the Clinical Global Impression Improvement (CGI-I) Scale and the Patient’s Global Impression of Change (PGIC) Scale.
Researchers tailored dosing through gradual increases and provided guidance for modifying the dose until satisfactory symptom control was reached or side effects were observed.
Results
After one month, six participants reported improvements, with five rating their change as a six on the PGIC scale. Only one patient, who received a chemotype 2 oral extract, noted no benefits, suggesting that inhaled THC or higher oral CBD doses may be more effective.
All participants tolerated the treatment well, with no reported side effects, which is vital for adherence. Younger patients may feel more comfortable with cannabis despite societal stigma.
Hypothesis
Researchers propose that exogenous cannabinoids could help restore the tonic activation of the endocannabinoid system (ECS) within the central nervous system (CNS). THC activates presynaptic CB1 receptors, and both cannabinoids interact with fatty-acid binding proteins (FABPs), possibly delaying the breakdown of anandamide.
High doses of oral CBD (800 mg/day) and patients treated with chemotype 1 flower exhibited elevated levels of circulating anandamide. It remains unclear if this results from CBD affecting anandamide transport or degradation or acting on other molecular targets. In contrast, psychiatric medications typically require 2-3 weeks to show initial effects, with longer durations necessary for patients to achieve remission.
Rapid symptom relief may be crucial during an “EUPD crisis,” when distressed patients may turn to benzodiazepines and other anxiety medications, leading to rapid tolerance and dependence.
Popular Cheap Cannabis Online for EUPD or BPD
If you seek to purchase cheap cannabis online for medical or recreational use, explore Haute Health Canada for a wide selection of cannabis products at competitive prices. Dispensaries offer Sativa strains for uplifting effects and Indica strains for relaxation, providing the best cannabis deals to suit different preferences.
Tip: Look for an online dispensary that offers same-day cannabis delivery and mail-order marijuana services. This ensures prompt and discreet packaging, utilizing Canada Post for secure shipping with tracking included. Buy cannabis online at Haute Health Canada.
Manage Behavioral Changes with Bulk Cannabis via Mail-Order Marijuana Service
Cannabinoids can effectively manage unstable personality disorders by targeting the ECS to regulate anandamide breakdown. Patients with EUPD may find relief by purchasing cannabis online or exploring affordable products to help with their symptoms.
An online cannabis store with same-day delivery or mail-order options strikes a balance between quality and affordability. Experience exceptional customer service from a friendly team and discover a variety of bulk cannabis strains, edibles, concentrates, and oils to enhance your journey. Buy cannabis online at Haute Health Canada.
Frequently Asked Questions
Does cheap marijuana equate to poor quality?
No, the price does not solely determine product quality. Assess quality by reviewing the product’s physical characteristics and personal experience. Some dispensaries lower prices through monthly or clearance sales. If a dispensary’s prices are significantly below industry norms, it may raise quality concerns.
Are there any adverse effects of marijuana when managing BPD?
Participants in the study reported no adverse side effects from marijuana. This is crucial for medication adherence, as a review of 36 studies indicated that side effects contributed to 28% of patients’ non-adherence to antipsychotics. A negative perception of antipsychotic medication was the second most common reason for intentional non-adherence, at 30.5%.
What is the fastest way to feel the effects of cannabinoids for an EUPD issue?
Smoking, vaping, and dabbing are the quickest methods to experience cannabinoid effects. In the study, participants utilized vaping for dried flower consumption. While smoking and vaping yield similar effects, the distinction lies in inhaling smoke versus vapor. Dabbing, involving concentrates, also results in rapid effects.
How often can I smoke or vape to manage my symptoms?
The effectiveness of cannabis strains and products varies based on individual response. In the study, researchers permitted patients to adjust their daily intake (between 0.5 and 2 grams daily) without exceeding monthly limits. For extracts, patients documented their daily dosages.
Related Articles:
